​

Mineralys Therapeutics Ownership | Who Owns Mineralys Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Mineralys Therapeutics Ownership Summary

Mineralys Therapeutics is owned by 100.34% institutional investors, 1.26% insiders. Catalys pacific is the largest institutional shareholder, holding 13.60% of MLYS shares.

MLYS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMineralys Therapeutics100.34%1.26%-1.60%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Catalys pacific8.90M13.60%$120.47M
Ra capital management6.15M9.39%$83.17M
Samsara biocapital5.67M8.67%$76.78M
Blackrock funding, inc. /de3.10M4.73%$41.91M
Capital investors2.90M4.43%$39.22M
Integral health asset management2.70M4.13%$36.53M
Laurion capital management lp1.76M2.69%$23.85M
Suvretta capital management1.74M2.67%$23.60M
Pictet asset management sa1.27M1.94%$17.16M
Jennison associates1.24M1.89%$16.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Catalys pacific8.90M91.50%$120.47M
Samsara biocapital5.67M15.70%$76.78M
22nw, lp560.04K4.77%$7.58M
Sectoral asset management382.42K3.42%$5.17M
Integral health asset management2.70M3.34%$36.53M
Stempoint capital lp631.59K2.74%$8.55M
Affinity asset advisors900.00K1.66%$12.18M
Sphera funds management480.97K1.53%$6.51M
Blue owl capital lp335.94K1.47%$4.55M
Ra capital management6.15M1.40%$83.17M

Top Buyers

HolderShares% AssetsChange
Capital investors2.90M0.01%2.90M
Orbimed advisors760.35K0.26%760.35K
Blackrock funding, inc. /de3.10M0.00%647.73K
Stempoint capital lp631.59K2.74%631.59K
Integral health asset management2.70M3.34%400.00K

Top Sellers

HolderShares% AssetsChange
Tcg crossover management---2.47M
Adams street partners---1.13M
Jennison associates1.24M0.01%-743.71K
Nantahala capital management353.98K0.19%-433.76K
Findell capital management---400.00K

New Positions

HolderShares% AssetsChangeValue
Capital investors2.90M0.01%2.90M$39.22M
Qube research351.11K0.00%351.11K$4.75M
Simplify asset management218.73K0.15%218.73K$8.29M
Armistice capital178.00K0.04%178.00K$2.41M
Exoduspoint capital management, lp172.55K0.02%172.55K$2.33M

Sold Out

HolderChange
Signaturefd-22.00
Golden state wealth management-32.00
Ronald blue trust-56.00
Creative planning-77.00
Srs capital advisors-108.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251663.75%65,673,2177.91%1000.77%1199.17%27-3.57%
Mar 31, 202515948.60%60,569,32731.79%1131.35%107-28-
Dec 31, 2024109-46,482,607-93-109---
Jun 30, 2024951.06%44,151,0375.44%891.03%6145.24%14-57.58%
Mar 31, 2024946.82%41,871,72920.62%931.01%42-27.59%33120.00%

Recent Insider Transactions

DateNameRoleActivityValue
Oct 13, 2025Levy Adam Scott CFO and SecretarySell$308.65K
Oct 13, 2025Levy Adam Scott CFO and SecretarySell$143.33K
Oct 13, 2025Congleton Jon Chief Executive OfficerSell$66.78K
Oct 13, 2025Congleton Jon Chief Executive OfficerSell$577.54K
Oct 15, 2025Rodman David Malcom Chief Medical OfficerSell$445.98K

Insider Transactions Trends

DateBuySell
2025 Q4-5
2025 Q3210
2025 Q2-9
2025 Q133
2024 Q4-4

MLYS Ownership FAQ

Who Owns Mineralys Therapeutics?

Mineralys Therapeutics shareholders are primarily institutional investors at 100.34%, followed by 1.26% insiders and -1.60% retail investors. The average institutional ownership in Mineralys Therapeutics's industry, Biotech Stocks , is 307.10%, which Mineralys Therapeutics falls below.

Who owns the most shares of Mineralys Therapeutics?

Mineralys Therapeutics’s largest shareholders are Catalys pacific (8.9M shares, 13.60%), Ra capital management (6.15M shares, 9.39%), and Samsara biocapital (5.67M shares, 8.67%). Together, they hold 31.67% of Mineralys Therapeutics’s total shares outstanding.

Does Blackrock own Mineralys Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Mineralys Therapeutics.

Who is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested?

Catalys pacific is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested, with 91.50% of its assets in 8.9M Mineralys Therapeutics shares, valued at 120.47M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools